Anti-Bribery and Anti-Corruption Policy
Anti-Bribery and Anti-Corruption Clause:
Both Parties warrant and represent that they have not taken and will not take any action that would constitute a violation, or implicate a violation, of any law of any jurisdiction in which it performs business, including any anti-corruption and anti-bribery law of any jurisdiction in which they perform business, or of the United States, of the European Union, or of the United Kingdom, including without limitation, the Korean Criminal Code and the Act on the Prohibition of Improper Solicitation and Provision/Receipt of Money and Valuables (i.e. the Kim Yong-Ran Act), the Foreign Corrupt Practices Act of 1977, as amended, the U.K. Bribery Act of 2010, any anti-corruption instruments of the European Union and where applicable, legislation enacted by member states and signatories implementing the OECD Convention Combating Bribery of Foreign Officials (“Anti-Corruption Laws”).
(Absence of) Conflict of Interest:
This Contract is entered into on a fair and arms-length basis, without duress or coercion, and is to be interpreted as an agreement between two parties of equal bargaining capacities. Notwithstanding any ties between the parties on ownership, affiliation or otherwise, the terms and conditions of the Contract are the same as they would have been, had the parties not have any relation with each other whatsoever.
This partnership holds no obligation to MMC to procure any products or drugs or services from your company in the future.
*Disclaimer Notice:
This is not applicable to transactions with government agencies. Please contact MakatiMed Compliance Department through email [email protected] for these transactions.
